The 2023 APAC Healthcare Conference was held in Hong Kong from 17th to 18th May. Representatives from leading companies in the fields of global pharmaceutical biotechnology, healthcare services, and medical devices attended the conference and discussed issues ranging from medical policies to innovative technologies. Charles Wang, Chief Executive Officer of Luye Medical Group, was invited to attend the keynote panel and shared his thoughts on the theme of “Healthcare Services – Balance of growth and profitability”.
He said: “Good doctors and good teams are always the focus of medical services, which can improve both operational efficiencies internally and improve patients’ experience externally, thereby achieving better treatment effects. At present, Luye Medical Group is committed to attracting, retaining, and cultivating talents with similar values, thus stimulating cooperation and productivity for healthy, sustainable development.” He also introduced the latest developments of Luye Medical’s business in China, Singapore, and Australia.
The panel was moderated by Kevin Qian, Managing Director and China Head of Global Asset Managers Investment Banking at Citi, with Zhiliang Tu, Founder, Chairman and CEO of Gushengtang, and Eva Huang, Managing Director of CBC Group discussing the topic from investment and Chinese medicine perspectives.
